GPR56, a novel platelet collagen receptor that loves stress.

J Thromb Haemost

School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University Walk, Bristol, UK.

Published: August 2021

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.15335DOI Listing

Publication Analysis

Top Keywords

gpr56 novel
4
novel platelet
4
platelet collagen
4
collagen receptor
4
receptor loves
4
loves stress
4
gpr56
1
platelet
1
collagen
1
receptor
1

Similar Publications

Targeting adhesion G protein-coupled receptors. Current status and future perspectives.

Structure

December 2024

Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Saxony, Germany. Electronic address:

Article Synopsis
  • * The unique structure and complex interactions of aGPCRs pose challenges in pharmacological studies, despite recent advancements in understanding their activation mechanisms and structures.
  • * This review focuses on small molecule ligands for the ADGRGs subfamily of aGPCRs, discussing the hurdles in drug discovery and the potential of these ligands for developing new therapies against various diseases.
View Article and Find Full Text PDF

Sensing steroid hormone 17α-hydroxypregnenolone by GPR56 enables protection from ferroptosis-induced liver injury.

Cell Metab

November 2024

Department of Cell Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Electronic address:

Article Synopsis
  • G protein-coupled receptors (GPCRs) play a key role in how cells respond to hormones and environmental signals, and this study focuses on their involvement in ferroptosis and liver injury.
  • Researchers found that the receptor GPR56 helps cells resist ferroptosis, and its absence worsens liver damage caused by drugs or lack of oxygen.
  • The study highlights 17α-hydroxypregnenolone (17-OH PREG) as a potential therapeutic agent that activates GPR56 to protect against ferroptosis and maintain liver health, while mutant forms of GPR56 fail to respond to this hormone.
View Article and Find Full Text PDF

The genetic cause of neurodevelopmental disorders in 30 consanguineous families.

Front Med (Lausanne)

August 2024

Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile Des Aveugles, Lausanne, Switzerland.

Objective: This study aims to clinically and genetically assess 30 unrelated consanguineous Pakistani families from various ethnic backgrounds, all exhibiting features of neurodevelopmental disorders (NDDs).

Methods: We conducted clinical, genetic, biochemical, and molecular analyses on 30 consanguineous families with NDDs enrolled from various regions of Pakistan. The likely molecular causes of primary microcephaly and NDDs were identified.

View Article and Find Full Text PDF

Background: The increasing prevalence of kidney diseases has become a significant public health issue, with a global prevalence exceeding 10%. In order to accurately identify biochemical changes and treatment outcomes associated with kidney diseases, novel methods targeting specific genes have been discovered. Among these genes, leucine-rich α-2 glycoprotein 1 (LRG1) has been identified to function as a multifunctional pathogenic signaling molecule in multiple diseases, including kidney diseases.

View Article and Find Full Text PDF

GPR56 is a widely expressed adhesion GPCR (AGPCR) that has pleotropic roles in brain development, platelet function, cancer, and more. Nearly all AGPCRs possess extracellular regions that bind protein ligands and conceal a cryptic tethered peptide agonist. AGPCR reception of mechanical or shear force is thought to release the tethered agonist permitting its binding to the AGPCR orthosteric site for consequent activation of G protein signaling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!